The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Good post krafty, and it is true in so many cases, and kinda reminds us how the setting was when Redmile came in with their investment.
None of us called that but it showed just how much work went on in the background before it could be announced. A reminder too born out of excitement that none of us with the best will in the world have called dates for news correctly either let alone funding. No news suggests there is nothing bad to report, good news best we collate it and add to it data over many indications and when the moment is right release it for maximum effect.Cases like Trish is what takes the eyes of participating trial hospitals and would explain the healthy update of patients into Scancell trials.
A very good post and reminder krafty, thanks for that ATB
Violindog, I notice you are thinking more about Redmiles position as our biggest shareholder.
I said from day one they must have had a Plan B in respect of their investment, and whether that means we did not have to rush to appoint CEO or know what results we will need for extra funding I have always felt they have had a bigger role to play on the business side other than passively holding share certificates.
Good posts, any other opinions?
Just a word on that 100k trade......................buy or sell??
I no longer call or try to trades like that, but at the time of the trade the spread was 15/15.50 and ticked up immediately to 16 on the ask, then soon after 16.50. I would say by that it was a buy.
Good to be able to put a face to Trish .Lindy must be thrilled.
Violindog, I was one of many who recommended your 10.52 post year but not in any way as TF says because is shows and proves up the level of frustration.
Far from it your post was very controlled and put forward options available that could be best serving for us shareholder.
TF, your constant conclusions re number of recs apply to you and not everybody else, my reason for reccing the post was simply because it was well written, without creating mass frustration, just a way this could be worked out in the months ahead. There are many options available.
Just to add, the certainty of our future plans for a 120 patient trial, sounds vvery much to me as if we know where funding will be coming from and that I guess will be dependant on results from the data we recover.
Your comments welcome.
AB, reasonable post, but even if Lindy is both CEO and CSO, do you really not think, there are many others inputting their commercial experiences and in particular Redmile and Vulpes.
Your post is certainly one way to see it, but I have always felt our two major shareholders have their Plan Bs and the ability to create commercial deals and are as we speak?
Jambonian, I would agree about the frustrations on this exchange, particularly this week, pretty normal for one poster to milk all the negativity possible when the opportunity arrives.
Whether it be Vulpes or Lindy talking about the 120 trial patients it is said very matter of factly with absolute certainty that the financial runway reflects something big going on in the background. I am pretty sure as I have said a few times that all parties would have been party to a Plan A,B or C in ensuring the necessary funding will be in place dependant on how positive selective data is when that time arrives.
Good posts yesterday guys, I am happy enough to trust the timelines that we are working too. I find it quiet staggering the amount of planning that has gone on to get this off the ground and through all the obstacles that COVID came with.
Keep the faith